Education
About Us
Working with TipRanks
Follow Us
Exact Sciences Corp. (EXAS)
NASDAQ:EXAS
Total Valuation
Exact Sciences has a market cap or net worth of $13.19B. The enterprise value is $11.89B.
Market Cap$13.19B
Enterprise Value$11.89B
Share Statistics
Exact Sciences has 189,471,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding189,471,300
Owned by Insiders1.05%
Owned by Institutions0.54%
Financial Efficiency
Exact Sciences’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -19.03%.
Return on Equity (ROE)-0.43
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-19.03%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee399.84K
Profits Per Employee-149.11K
Employee Count6,900
Asset Turnover0.47
Inventory Turnover5.17
Valuation Ratios
The current PE Ratio of Exact Sciences is ―. Exact Sciences’s PEG ratio is -0.03.
PE Ratio―
PS Ratio3.75
PB Ratio4.31
Price to Fair Value4.31
Price to FCF138.84
Price to Operating Cash Flow34.07
PEG Ratio-0.03
Income Statement
In the last 12 months, Exact Sciences had revenue of 2.76B and earned -1.03B in profits. Earnings per share was -5.59.
Revenue2.76B
Gross Profit1.92B
Operating Income-1.05B
Pretax Income-1.04B
Net Income-1.03B
EBITDA-788.73M
Earnings Per Share (EPS)-5.59
Cash Flow
In the last 12 months, operating cash flow was 386.81M and capital expenditures -139.73M, giving a free cash flow of 247.08M billion.
Operating Cash Flow386.81M
Free Cash Flow247.08M
Free Cash Flow per Share1.30
Dividends & Yields
Exact Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change30.57%
50-Day Moving Average57.70
200-Day Moving Average51.70
Relative Strength Index (RSI)67.82
Average Volume (3m)2.47M
Important Dates
Exact Sciences upcoming earnings date is Feb 24, 2026, After Close (Confirmed).
Last Earnings DateNov 3, 2025
Next Earnings DateFeb 24, 2026
Ex-Dividend Date―
Financial Position
Exact Sciences as a current ratio of 2.15, with Debt / Equity ratio of 100.80%
Current Ratio2.15
Quick Ratio1.92
Debt to Market Cap0.25
Net Debt to EBITDA-2.73
Interest Coverage Ratio-32.80
Taxes
In the past 12 months, Exact Sciences has paid -7.30M in taxes.
Income Tax-7.30M
Effective Tax Rate<0.01
Enterprise Valuation
Exact Sciences EV to EBITDA ratio is -15.85, with an EV/FCF ratio of 167.73.
EV to Sales4.53
EV to EBITDA-15.85
EV to Free Cash Flow167.73
EV to Operating Cash Flow59.39
Balance Sheet
Exact Sciences has $1.00B in cash and marketable securities with $2.54B in debt, giving a net cash position of -$1.53B billion.
Cash & Marketable Securities$1.00B
Total Debt$2.54B
Net Cash-$1.53B
Net Cash Per Share-$8.09
Tangible Book Value Per Share-$5.29
Margins
Gross margin is 67.36%, with operating margin of -38.01%, and net profit margin of -37.29%.
Gross Margin67.36%
Operating Margin-38.01%
Pretax Margin-37.56%
Net Profit Margin-37.29%
EBITDA Margin-28.59%
EBIT Margin-36.40%
Analyst Forecast
The average price target for Exact Sciences is $76.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$76.43
Price Target Upside9.77% Upside
Analyst ConsensusStrong Buy
Analyst Count18
Revenue Growth Forecast14.47%
EPS Growth Forecast-353.69%